Procainamide vs Lidocaine for Converting VT with a Pulse

Introduction to Procainamide and Lidocaine

• The American College of Cardiology recommends procainamide for patients with hemodynamically stable monomorphic VT who do not have severe congestive heart failure or acute myocardial infarction 2, 3
• The American Heart Association states that lidocaine is considered second-line antiarrhythmic therapy for monomorphic VT, with conversion effectiveness of only approximately 20% 4

Clinical Guidelines for Drug Selection

• The American College of Cardiology suggests choosing procainamide when a patient has hemodynamically stable monomorphic VT with pulse, no severe congestive heart failure, and no acute myocardial infarction 2, 3
• The American Heart Association recommends choosing lidocaine when VT occurs in the setting of acute myocardial infarction, or when procainamide is contraindicated 5, 6

Dosing Regimens

• The Journal of the American College of Cardiology recommends a procainamide loading infusion of 10-15 mg/kg at 20-50 mg/min, with a maintenance infusion of 1-4 mg/min 5, 6, 7
• The American College of Cardiology suggests an initial lidocaine bolus of 1.0-1.5 mg/kg, with additional boluses of 0.5-0.75 mg/kg every 5-10 minutes up to a total of 3 mg/kg 5, 4

Critical Safety Considerations

• The American College of Cardiology warns that procainamide may cause proarrhythmia, including torsades de pointes, and requires monitoring for hypotension and negative inotropic effects 5, 6, 7
• The American Heart Association advises reducing the dose of procainamide in renal insufficiency due to NAPA accumulation 5, 6

Mechanism of Superior Efficacy

• The Journal of the American College of Cardiology explains that procainamide's superior performance relates to its electrophysiologic effects, including significant prolongation of the effective refractory period of the ventricle, HV interval, and QRS duration 6, 7
• The American College of Cardiology states that procainamide's Class Ia sodium channel blockade with intermediate kinetics provides a more sustained antiarrhythmic effect 6, 7